What is included with each IGF-1 LR3 Liquid Spray
In a randomized, double-blind, placebo-controlled trial, tesamorelin reduced liver fat and was associated with less fibrosis progression, and a targeted proteomic and transcriptomic analysis of that trial showed the drug lowered fibro-inflammatory mediators including VEGFA, TGF-1, and CSF1
Contact SeeBeyond Medicine today and take the first step towards a healthier, joyful life
Body composition Explored in research on lean mass and fat distribution through the GH/IGF-1 axis
2012;7(6):e38901
study demonstrated that ipamorelin: Released GH in a dose-dependent manner Did not significantly elevate cortisol levels, even at high doses Did not significantly elevate prolactin levels Did not significantly affect ACTH, FSH, LH, or TSH (4) This selectivity gives ipamorelin a notably clean side-effect profile compared to other GH secretagogues